Ergänzende Abbildung S2 zur Tyrosin-Protein-Kinase SYK-bezogenen Gen-Signatur in Baseline-Immunzellen, die mit immuntherapieinduzierten immunbedingten Nebenwirkungen bei Melanomen assoziiert ist

Monson et al. (Di,) untersuchten diese Fragestellung.

www.synapsesocial.com/papers/68e56226e2b3180350efee71 — DOI: https://doi.org/10.1158/1078-0432.27142345

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Supplementary Figure S7 from Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma· 2024
2. Supplementary Figure S4 from Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma· 2024
3. Supplementary Figure S3 from Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma· 2024
4. Supplementary Figure S5 from Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma· 2024
5. Supplementary Figure S1 from Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma· 2024